Evidence Question
What does direct evidence report when empagliflozin is compared with glimepiride for brachial artery flow mediated dilation fmd?
Related to: Cardiovascular RiskShort answer
In indexed direct evidence at the reported timepoint, no difference was reported for brachial artery flow mediated dilation fmd.
Why do we say this?
The available direct comparison reported no difference for this outcome at the reported timepoint, but the head-to-head evidence base is limited.